<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36226148</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and rheumatic diseases: A mini-review.</ArticleTitle><Pagination><StartPage>997876</StartPage><MedlinePgn>997876</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">997876</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.997876</ELocationID><Abstract><AbstractText>Joint pain and arthralgia can be manifestations of COVID-19, and studies evaluating long COVID symptoms identified the persistence of these disorders. Moreover, some case reports highlighted the development of new inflammatory arthritis in patients with COVID-19, suggesting a possible relation. Viral infections and rheumatic diseases share a documented relationship; they have been associated with genetic and environmental risk factors responsible for some of them. There is crosstalk between viruses and the immune system during the development of several rheumatic diseases. Moreover, infections may participate in the pathogenesis of autoimmune rheumatic diseases and contribute to patient mortality. Therefore, it is crucial to provide a clearer insight into the interaction between viral infections and rheumatic diseases. Here, we provide a mini-review of the current literature with the aim of shedding light on the relationship between COVID-19 and rheumatic or musculoskeletal diseases, which is still unclear. Specifically, we examined several aspects: risk for the rheumatic population of acquiring the virus or developing severe symptoms, similarities of COVID-19 and arthritis, the possible rheumatic consequence of COVID-19, of rheumatic drugs and vaccines, and COVID-19 prevention in rheumatic patients through vaccination.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Roseti and Grigolo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roseti</LastName><ForeName>Livia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>SSD Laboratorio RAMSES, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grigolo</LastName><ForeName>Brunella</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>SSD Laboratorio RAMSES, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">musculoskeletal pain</Keyword><Keyword MajorTopicYN="N">reactive arthritis</Keyword><Keyword MajorTopicYN="N">rheumatic diseases</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>2</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36226148</ArticleId><ArticleId IdType="pmc">PMC9548696</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.997876</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int. (2021) 41:2031&#x2013;9. 10.1007/s00296-021-04998-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04998-x</ArticleId><ArticleId IdType="pmc">PMC8456072</ArticleId><ArticleId IdType="pubmed">34550429</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727&#x2013;33. 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. . Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. (2016) 24:490&#x2013;502. 10.1016/j.tim.2016.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.03.003</ArticleId><ArticleId IdType="pmc">PMC7125511</ArticleId><ArticleId IdType="pubmed">27012512</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R, Patel KJ, Ranjan K. COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies. Biomolecules. (2021) 11:993. 10.3390/biom11070993</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11070993</ArticleId><ArticleId IdType="pmc">PMC8301790</ArticleId><ArticleId IdType="pubmed">34356617</ArticleId></ArticleIdList></Reference><Reference><Citation>Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol. (2022) 18:191&#x2013;204. 10.1038/s41584-022-00755-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-022-00755-x</ArticleId><ArticleId IdType="pmc">PMC8874732</ArticleId><ArticleId IdType="pubmed">35217850</ArticleId></ArticleIdList></Reference><Reference><Citation>Grainger R, Machado PM, Robinson PC. Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes. Best Pract Res Clin Rheumatol. (2021) 35:101657. 10.1016/j.berh.2020.101657</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2020.101657</ArticleId><ArticleId IdType="pmc">PMC7756169</ArticleId><ArticleId IdType="pubmed">33468418</ArticleId></ArticleIdList></Reference><Reference><Citation>Landew&#xe9; RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, et al. . EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. (2020) 79:851&#x2013;8. 10.1136/annrheumdis-2020-217877</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217877</ArticleId><ArticleId IdType="pubmed">32503854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, et al. . American college of rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3. Arthritis Rheumatol. (2021) 73:e1&#x2013;e12. 10.1002/art.41596</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41596</ArticleId><ArticleId IdType="pubmed">33277981</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson PC, Bursle EC. Management of autoimmune disease during the COVID-19 pandemic. Aust Prescr. (2020) 43:146&#x2013;7. 10.18773/austprescr.2020.058</Citation><ArticleIdList><ArticleId IdType="doi">10.18773/austprescr.2020.058</ArticleId><ArticleId IdType="pmc">PMC7572196</ArticleId><ArticleId IdType="pubmed">33093739</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou R, Dana T, Jungbauer R, Weeks C, McDonagh MS. Update alert 6: masks for prevention of respiratory virus infections, including SARS-CoV-2, in health care and community settings. Ann Intern Med. (2020) 173:W86. 10.7326/L20-0948</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-0948</ArticleId><ArticleId IdType="pmc">PMC7384263</ArticleId><ArticleId IdType="pubmed">32687391</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza LR, Garc&#xed;a-Valladares I. Of bugs and joints: the relationship between infection and joints. Reumatol Clin. (2013) 9:229&#x2013;38. 10.1016/j.reumae.2012.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reumae.2012.10.004</ArticleId><ArticleId IdType="pubmed">22944142</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. (2011) 31:1409&#x2013;17. 10.1007/s00296-011-1999-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1999-3</ArticleId><ArticleId IdType="pubmed">21800117</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Torres MK, Bichara CDA, de Almeida MNDS, Vallinoto MC, Queiroz MAF, Vallinoto IMVC, et al. . The complexity of SARS-CoV-2 infection and the COVID-19 pandemic. Front Microbiol. (2022) 13:789882. 10.3389/fmicb.2022.789882</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.789882</ArticleId><ArticleId IdType="pmc">PMC8870622</ArticleId><ArticleId IdType="pubmed">35222327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271&#x2013;80. 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. (2020) 367:1444&#x2013;8. 10.1126/science.abb2762</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chams N, Chams S, Badran R, Shams A, Araji A, Raad M et al. COVID-19: a multidisciplinary review. Front Public Health. (2020) 8:383. 10.3389/fpubh.2020.00383</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00383</ArticleId><ArticleId IdType="pmc">PMC7403483</ArticleId><ArticleId IdType="pubmed">32850602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the &#x2018;cytokine storm&#x2019; in COVID-19. J Infect. (2020) 80:607&#x2013;13. 10.1016/j.jinf.2020.03.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. (2021) 20:102792. 10.1016/j.autrev.2021.102792</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Liu S, Liu J, Liu J, Zhang Z, Wan X, et al. . COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther. (2020) 5:128. 10.1038/s41392-020-00243-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00243-2</ArticleId><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A Proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. (2020) 324:2251&#x2013;2. 10.1001/jama.2020.22717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Prather KA, Wang CC, Schooley RT. Reducing transmission of SARS-CoV-2. Science. (2020) 368:1422&#x2013;24. 10.1126/science.abc6197</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6197</ArticleId><ArticleId IdType="pubmed">32461212</ArticleId></ArticleIdList></Reference><Reference><Citation>Almoallim H, Cheikh M. Skills in Rheumatology. Singapore: Springer; (2021). 10.1007/978-981-15-8323-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-8323-0</ArticleId><ArticleId IdType="pubmed">36315663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. (2019) 393:1745&#x2013;59. 10.1016/S0140-6736(19)30417-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30417-9</ArticleId><ArticleId IdType="pubmed">31034380</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway R, Konig MF, Graef ER, Webb K, Yazdany J, Kim AHJ. Inflammatory arthritis in patients with COVID-19. Transl Res. (2021) 232:49&#x2013;59. 10.1016/j.trsl.2021.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.02.010</ArticleId><ArticleId IdType="pmc">PMC7897406</ArticleId><ArticleId IdType="pubmed">33626415</ArticleId></ArticleIdList></Reference><Reference><Citation>Calle E, G&#xf3;mez-Puerta JA. &#x201c;The spectrum of rheumatic diseases&#x201d; In: Atzeni F, Masala IF, Aletaha D, Lee M, Baraliakos X, editors. The Handbook of Systemic Autoimmune Diseases. Amsterdam: Elsevier; (2018). p. 1&#x2013;13. 10.1016/B978-0-444-63887-8.00001-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63887-8.00001-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. (2012) 64:1697&#x2013;707. 10.1002/art.34453</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34453</ArticleId><ArticleId IdType="pmc">PMC3366018</ArticleId><ArticleId IdType="pubmed">22392533</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. . Rheumatoid arthritis. Nat Rev Dis Primers. (2018) 4:18001. 10.1038/nrdp.2018.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.1</ArticleId><ArticleId IdType="pubmed">29417936</ArticleId></ArticleIdList></Reference><Reference><Citation>Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. (2021) 10:2857. 10.3390/cells10112857</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112857</ArticleId><ArticleId IdType="pmc">PMC8616326</ArticleId><ArticleId IdType="pubmed">34831081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekaryssova D, Yessirkepov M, Zimba O, Gasparyan AY, Ahmed S. Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol. (2022) 41:1641&#x2013;52. 10.1007/s10067-022-06120-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06120-3</ArticleId><ArticleId IdType="pmc">PMC8898028</ArticleId><ArticleId IdType="pubmed">35247132</ArticleId></ArticleIdList></Reference><Reference><Citation>Borja Del Carmelo G, S&#xe1;ez L, Pallar&#xe9;s L, Velilla J, Mar&#xed;n A, Martinez-Lostao L, et al. . COVID GEAS: COVID-19 national survey in patients with systemic autoimmune diseases. Kk Front Med. (2021) 8:808608. 10.3389/fmed.2021.808608</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.808608</ArticleId><ArticleId IdType="pmc">PMC8828974</ArticleId><ArticleId IdType="pubmed">35155485</ArticleId></ArticleIdList></Reference><Reference><Citation>Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? Arthritis Rheumatol. (2020) 72:1600&#x2013;06. 10.1002/art.41388</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41388</ArticleId><ArticleId IdType="pmc">PMC7300434</ArticleId><ArticleId IdType="pubmed">32506699</ArticleId></ArticleIdList></Reference><Reference><Citation>Strangfeld A, Sch&#xe4;fer M, Gianfrancesco MA, Lawson-Tovey S, Liew Jean W, Ljung L, et al. . Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis. (2021) 80:930&#x2013;42. 10.1136/annrheumdis-2020-219498</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219498</ArticleId><ArticleId IdType="pmc">PMC7843211</ArticleId><ArticleId IdType="pubmed">33504483</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, et al. . Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. (2020) 102:1197&#x2013;204. 10.2106/JBJS.20.00847</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.20.00847</ArticleId><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragni E, Mangiavini L, Vigan&#xf2; M, Brini AT, Peretti GM, Banfi G, et al. . Management of osteoarthritis during the COVID-19 pandemic. Clin Pharmacol Ther. (2020) 108:719&#x2013;29. 10.1002/cpt.1910</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1910</ArticleId><ArticleId IdType="pmc">PMC7280639</ArticleId><ArticleId IdType="pubmed">32438454</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwers M, Au M, Yuan S, Wen C. COVID-19 in joint ageing and osteoarthritis: current status and perspectives. Int J Mol Sci. (2022) 23:720. 10.3390/ijms23020720</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020720</ArticleId><ArticleId IdType="pmc">PMC8775477</ArticleId><ArticleId IdType="pubmed">35054906</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewanjee S, Kandimalla R, Kalra RS, Valupadas C, Vallamkondu J, Kolli V, et al. . COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges. Cells. (2021) 10:3291. 10.3390/cells10123291</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123291</ArticleId><ArticleId IdType="pmc">PMC8699554</ArticleId><ArticleId IdType="pubmed">34943795</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group . Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. (2021) 326:499&#x2013;518. 10.1001/jama.2021.11330</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11330</ArticleId><ArticleId IdType="pmc">PMC8261689</ArticleId><ArticleId IdType="pubmed">34228774</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonelli M, Dalwigk K, Platzer A, Olmos Calvo I, Hayer S, Niederreiter B, et al. . IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes. Exp Mol Med. (2019) 51:1&#x2013;11. 10.1038/s12276-019-0267-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0267-6</ArticleId><ArticleId IdType="pmc">PMC6802656</ArticleId><ArticleId IdType="pubmed">31285419</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, et al. . COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. (2021) 6:e147413. 10.1172/jci.insight.147413</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147413</ArticleId><ArticleId IdType="pmc">PMC8328085</ArticleId><ArticleId IdType="pubmed">34143756</ArticleId></ArticleIdList></Reference><Reference><Citation>Putman M, Chock Y, Tam H, Kim A, Sattui SE, Berenbaum F, et al. . Antirheumatic disease therapies for the treatment of COVID-19: a systematic review and meta-analysis. Arthritis Rheum. (2021) 73:36&#x2013;47. 10.1002/art.41469</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41469</ArticleId><ArticleId IdType="pmc">PMC7435536</ArticleId><ArticleId IdType="pubmed">32741139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou&#xe9;draogo DD, Tiendr&#xe9;b&#xe9;ogo WJS, Kabor&#xe9; F, Ntsiba H. COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments. Clin Rheumatol. (2020) 39:2069&#x2013;75. 10.1007/s10067-020-05189-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05189-y</ArticleId><ArticleId IdType="pmc">PMC7256179</ArticleId><ArticleId IdType="pubmed">32472461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. (2020) 10:1539&#x2013;54. 10.1007/s00296-020-04639-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04639-9</ArticleId><ArticleId IdType="pmc">PMC7360125</ArticleId><ArticleId IdType="pubmed">32666137</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, et al. . DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: a prospective study. Arthritis Rheum. (2022) 9. 10.1101/2022.02.08.22270696</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.08.22270696</ArticleId><ArticleId IdType="pmc">PMC9116968</ArticleId><ArticleId IdType="pubmed">35617780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. (2021) 40:2611&#x2013;9. 10.1007/s10067-021-05691-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05691-x</ArticleId><ArticleId IdType="pmc">PMC7968918</ArticleId><ArticleId IdType="pubmed">33733315</ArticleId></ArticleIdList></Reference><Reference><Citation>Schett G, Manger B, Simon D, Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. (2020) 16:465&#x2013;70. 10.1038/s41584-020-0451-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0451-z</ArticleId><ArticleId IdType="pmc">PMC7304381</ArticleId><ArticleId IdType="pubmed">32561873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, et al. . Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol. (2021) 61:45. 10.1186/s42358-021-00204-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-021-00204-5</ArticleId><ArticleId IdType="pmc">PMC8264991</ArticleId><ArticleId IdType="pubmed">34238376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S, Taniguchi Y, Kida I, Tamura N. SARS-CoV2-triggered acute arthritis: viral arthritis rather than reactive arthritis. J Med Virol. (2021) 93:6458&#x2013;9. 10.1002/jmv.27229</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27229</ArticleId><ArticleId IdType="pmc">PMC8426820</ArticleId><ArticleId IdType="pubmed">34297354</ArticleId></ArticleIdList></Reference><Reference><Citation>De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. (2020). 10.1136/annrheumdis-2020-218520</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218520</ArticleId><ArticleId IdType="pubmed">32753423</ArticleId></ArticleIdList></Reference><Reference><Citation>Coath FL, Mackay J, Gaffney JK. Axial presentation of reactive arthritis secondary to Covid-19 infection. Rheumatology. (2021) 60:e232-3. 10.1093/rheumatology/keab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab009</ArticleId><ArticleId IdType="pmc">PMC7928576</ArticleId><ArticleId IdType="pubmed">33471106</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Gonz&#xe1;lez MDC, Peral-Garrido ML, Calabuig I, Tovar-Sugra&#xf1;es E, Jovani V, Bernabeu P, et al. . Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. (2020) 80:e58. 10.1136/annrheumdis-2020-217914</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217914</ArticleId><ArticleId IdType="pubmed">32471899</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B, et al. . Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2: a systematic review. J Pediatr. (2020) 226:45&#x2013;54e1. 10.1016/j.jpeds.2020.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7403869</ArticleId><ArticleId IdType="pubmed">32768466</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L, Gianotti G, Gravina D, Attolini G, Zanelli G, Della Rosa N, et al. . Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: a causal link? Med Hypotheses. (2021) 153:110638. 10.1016/j.mehy.2021.110638</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110638</ArticleId><ArticleId IdType="pmc">PMC8223113</ArticleId><ArticleId IdType="pubmed">34217126</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado E, Gratac&#xf3;s J, Tolosa C, Mart&#xed;nez JM, Ojanguren I, Ariza A., et al. . Antimalarial myopathy: an underdiagnosed complication? prospective longitudinal study of 119 patients. Ann Rheum Dis. (2006) 65:385&#x2013;90. 10.1136/ard.2004.023200</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2004.023200</ArticleId><ArticleId IdType="pmc">PMC1798076</ArticleId><ArticleId IdType="pubmed">16096334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandwani A, Shuter J. Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. Ther Clin Risk Manag. (2008) 4:1023&#x2013;33. 10.2147/TCRM.S3285</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S3285</ArticleId><ArticleId IdType="pmc">PMC2621403</ArticleId><ArticleId IdType="pubmed">19209283</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik GS, Tyagi MG. A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection. J Clin Exp Hepatol. (2012) 2:42&#x2013;54. 10.1016/S0973-6883(12)60090-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0973-6883(12)60090-5</ArticleId><ArticleId IdType="pmc">PMC3940409</ArticleId><ArticleId IdType="pubmed">25755405</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarras A, Emery P, Vital EM. Type I interferon&#x2013;mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. Rheumatology. (2017) 56:1662&#x2013;75. 10.1093/rheumatology/kew431</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew431</ArticleId><ArticleId IdType="pubmed">28122959</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrone L, Picchianti-Diamanti A, Sebastiani GD, Aiello A, Lagan&#xe0; B, Cuzzi G, et al. . Humoral and cellular responses to spike of &#x3b4; SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases. Int J Infect Dis. (2022) 121:24&#x2013;30. 10.1016/j.ijid.2022.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.04.027</ArticleId><ArticleId IdType="pmc">PMC9023365</ArticleId><ArticleId IdType="pubmed">35462039</ArticleId></ArticleIdList></Reference><Reference><Citation>Soy M, Keser G, Atagunduz P, Mutlu MY, Gunduz A, Koyba&#x15f;i G, et al. . A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol. (2021) 40:3533&#x2013;5. 10.1007/s10067-021-05700-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05700-z</ArticleId><ArticleId IdType="pmc">PMC7982510</ArticleId><ArticleId IdType="pubmed">33751280</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkhalifa D, Rayan M, Negmeldin AT, Elhissi A, Khalil A. Chemically modified mRNA beyond COVID-19: potential preventive and therapeutic applications for targeting chronic diseases. Biomed Pharmacother. (2022) 145:112385. 10.1016/j.biopha.2021.112385</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112385</ArticleId><ArticleId IdType="pmc">PMC8552589</ArticleId><ArticleId IdType="pubmed">34915673</ArticleId></ArticleIdList></Reference><Reference><Citation>Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, et al. . Incidence and prevalence of vaccine preventable infections in adult patients with auto-immune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD open. (2019) 5:e001041. 10.1136/rmdopen-2019-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2019-001041</ArticleId><ArticleId IdType="pmc">PMC6803008</ArticleId><ArticleId IdType="pubmed">31673420</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasselt M, Wagner U, Nguyen P, Pietsch C, Boldt A, Baerwald C, et al. . Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions. Rheumatology. (2022) 61:SI180&#x2013;8. 10.1093/rheumatology/keac089</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac089</ArticleId><ArticleId IdType="pmc">PMC8903382</ArticleId><ArticleId IdType="pubmed">35143648</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Liu Y, Liu Y. The flare of rheumatic disease after SARS-CoV-2 vaccination: a review. Front Immunol. (2022) 13:919979. 10.3389/fimmu.2022.919979</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.919979</ArticleId><ArticleId IdType="pmc">PMC9289284</ArticleId><ArticleId IdType="pubmed">35860285</ArticleId></ArticleIdList></Reference><Reference><Citation>An Q-J, Qin D-A, Pei J-X. Reactive arthritis after COVID- 19 vaccination. Hum Vaccin Immunother. (2021) 17:2954&#x2013;6. 10.1080/21645515.2021.1920274</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1920274</ArticleId><ArticleId IdType="pmc">PMC8381833</ArticleId><ArticleId IdType="pubmed">34033732</ArticleId></ArticleIdList></Reference><Reference><Citation>Unal Enginar A. Arthritis following COVID-19 vaccination: report of two cases. Int Immunopharmacol. (2021) 101:108256. 10.1016/j.intimp.2021.108256</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108256</ArticleId><ArticleId IdType="pmc">PMC8516724</ArticleId><ArticleId IdType="pubmed">34673298</ArticleId></ArticleIdList></Reference><Reference><Citation>Reactions Weekly . SARS-CoV-2-Vaccine-Inactivated-Sinovac-Biotech. (2022). 10.1007/s40278-022-09226-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40278-022-09226-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection. Int J Rheum Dis. (2021) 24:1218&#x2013;20. 10.1111/1756-185X.14202</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14202</ArticleId><ArticleId IdType="pmc">PMC8441889</ArticleId><ArticleId IdType="pubmed">34363344</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C, Makhmudov S, Botabekova A. Seropositive rheumatoid arthritis after vaccination against SARSCoV-2 infection. Int J Rheum Dis. (2021) 24:1440&#x2013;1. 10.1111/1756-185X.14220</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14220</ArticleId><ArticleId IdType="pmc">PMC8652505</ArticleId><ArticleId IdType="pubmed">34585843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang KT, Hsu BC, Chen DY. Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis. Biomedicines. (2022) 10:834. 10.3390/biomedicines10040834</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040834</ArticleId><ArticleId IdType="pmc">PMC9030402</ArticleId><ArticleId IdType="pubmed">35453585</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, et al. . American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3. Arthritis Rheumatol. (2021) 73:e60&#x2013;75. 10.1002/art.41928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41928</ArticleId><ArticleId IdType="pmc">PMC8426685</ArticleId><ArticleId IdType="pubmed">34346564</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly CM, Ruddy JA, Boyarsky BJ, Barbur I, Werbel WA, Geetha D, et al. . Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two-dose SARS-CoV-2 messenger RNA vaccination. Arthritis Rheumatol. (2022) 74:28&#x2013;32. 10.1002/art.41924</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41924</ArticleId><ArticleId IdType="pmc">PMC8712346</ArticleId><ArticleId IdType="pubmed">34346185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>